Just like earlier this year with Martin Shkreli and Daraprim, the Internet is full of outrage the past few days over the action of Mylan CEO Heather Fausch to raise the price of the live-saving drug EpiPen to $500 per unit. And as always happens, politicians are getting into the act, particularly Hillary Clinton, who raged that Mylan must reduce the price immediately - as if pharmaceutical companies check with candidates for political office in setting their pricing. But if Hillary really wants to manifest her rage - as if it were anything but calculated for her own benefit - she should turn it inward toward herself and the Democratic Party. Because everything about this can be traced back to Democrats. Let's start with the fact that Fausch is the daughter of U.S. Senator Joe Manchin (D-West Virginia). That makes it a little awkward for the denizens of Washington to haul her in front of congressional committees for a grilling on her greed, you think? But the truly uncomfortable truth for Democrats is that the EpiPen price spike is not so much the product of "greed" as it is the product of one company having a monopoly. And that the direct result of the Democrat-controlled Food and Drug Administration's persistent refusal to allow anyone to compete with Mylan in the sale of EpiPen, as the Wall Street Journal explains:

---

Support Canada Free Press

---